Trial Information

Summary: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study Of Renzapride in Women with Constipation-Predominant Irritable Bowel Syndrome

Toledo Center for Clinical Research is seeking women 18 to 65 to test an investigational medication for constipation-type IBS. Qualified participants receive study medication and study related exams at no cost, and compensation. Call 419-885-5163

Patient Inclusion Criteria:

  • Women ages 18 to 65
  • Documented Constipation-type IBS BMI 19-39

Patient Exclusion Criteria:

  • Subjects with concerning signs like rectal bleeding or anemia in the past 3 months
  • Women who are pregnant and lactating
  • Family History of Hereditary Non-Polyposis Colorectal Cancer in the past 2 yrs.
  • Participated in another study in the past 90 days

Contact:

Delaine Douglas, Study Coordinator
Toledo Center for Clinical Research (TCCR)
5860 W. Alexis Rd. Suite B
Sylvania, OH 43560
Telephone: 419--885-5163
Fax: 419-885-1758
Email:

Profile Page: Toledo Center for Clinical Research (TCCR), Sylvania, OH

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:37 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA